Capital Markets Assignment

Hamilton adviser in connection with EQT’s offer on Karo Pharma

Hamilton acts for Karo Pharma AB in con­nec­tion with EQT’s rec­om­mend­ed pub­lic ten­der of­fer on Karo Pharma. The of­fer amounts to in to­tal ap­prox­i­mate­ly SEK 6 bil­lion. Completion of the of­fer is con­di­tion­al up­on cus­tom­ary con­di­tions and the ac­cep­tance pe­ri­od is ex­pect­ed to com­mence on or about 13 November 2018.

Karo Pharma is a Specialty Pharma com­pa­ny, which de­vel­ops and mar­kets prod­ucts for phar­ma­cies as well as di­rect­ly to the health­care sec­tor. Karo Pharma is list­ed on Nasdaq Stockholm, Mid Cap.

More news

More Assignments